En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase-2 as a Target for Kunitz-Type Inhibitors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
En Route to New Therapeutic Options for Iron Overload Diseases: Matriptase-2 as a Target for Kunitz-Type Inhibitors
Authors
Keywords
-
Journal
CHEMBIOCHEM
Volume 17, Issue 7, Pages 595-604
Publisher
Wiley
Online
2016-01-14
DOI
10.1002/cbic.201500651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell surface serine protease matriptase-2 suppresses fetuin-A/AHSG-mediated induction of hepcidin
- (2015) Marit Stirnberg et al. BIOLOGICAL CHEMISTRY
- Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease
- (2015) Benedikt Schaefer et al. HUMAN MOLECULAR GENETICS
- Identification of TMPRSS6 cleavage sites of hemojuvelin
- (2015) Marco Rausa et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Analysis of Subpocket Selectivity and Identification of Potent Selective Inhibitors for Matriptase and Matriptase-2
- (2014) Dominic Duchêne et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cleavage Specificity Analysis of Six Type II Transmembrane Serine Proteases (TTSPs) Using PICS with Proteome-Derived Peptide Libraries
- (2014) Olivier Barré et al. PLoS One
- Hepatocyte growth factor activator inhibitor type 2 (HAI-2) modulates hepcidin expression by inhibiting the cell surface protease matriptase-2
- (2013) Eva Maurer et al. BIOCHEMICAL JOURNAL
- Substrate specificity of human matriptase-2
- (2013) M. Wysocka et al. BIOCHIMIE
- Inhibiting the hepcidin inhibitor for treatment of iron overload
- (2013) L. Silvestri BLOOD
- Striking the target in iron overload disorders
- (2013) Karin E. Finberg JOURNAL OF CLINICAL INVESTIGATION
- Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
- (2013) Shuling Guo et al. JOURNAL OF CLINICAL INVESTIGATION
- Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines
- (2012) Stefan Dosa et al. BIOORGANIC & MEDICINAL CHEMISTRY
- An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/- mice and ameliorates anemia and iron overload in murine -thalassemia intermedia
- (2012) P. J. Schmidt et al. BLOOD
- Deletion of TMPRSS6 attenuates the phenotype in a mouse model of -thalassemia
- (2012) A. Nai et al. BLOOD
- Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6
- (2012) Pauline Lee et al. BLOOD CELLS MOLECULES AND DISEASES
- Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
- (2011) K. E. Finberg et al. BLOOD
- Insights into Matriptase-2 Substrate Binding and Inhibition Mechanisms by Analyzing Active-Site-Mutated Variants
- (2011) Eva Maurer et al. ChemMedChem
- Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface
- (2010) Marit Stirnberg et al. BIOCHEMICAL JOURNAL
- Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis
- (2010) K. E. Finberg et al. BLOOD
- Mechanisms of Macromolecular Protease Inhibitors
- (2010) Christopher J. Farady et al. CHEMBIOCHEM
- Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1)
- (2010) Charles Eigenbrot et al. FEBS Journal
- Matriptase-2- and Proprotein Convertase-cleaved Forms of Hemojuvelin Have Different Roles in the Down-regulation of Hepcidin Expression
- (2010) Julia E. Maxson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2
- (2010) Mihiret Tekeste Sisay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice
- (2009) R. Szabo et al. DEVELOPMENT
- Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides
- (2009) François Béliveau et al. FEBS Journal
- Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
- (2008) A. R. Folgueras et al. BLOOD
- The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
- (2008) Laura Silvestri et al. Cell Metabolism
- Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
- (2008) Andreas Lehmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
- (2008) Karin E Finberg et al. NATURE GENETICS
- The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
- (2008) X. Du et al. SCIENCE
- Zymogen activation, inhibition, and ectodomain shedding of matriptase
- (2007) Chen-Yong Lin Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started